Financial Summary (All financials)
In millions, except per share items | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
Revenues | 278.9 | 241.6 | 186.1 | 131.2 | 106.0 |
Revenue growth | 15.4% | 29.8% | 41.9% | 23.8% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 26.6 |
Gross profit | 278.9 | 241.6 | 186.1 | 131.2 | 79.4 |
Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 74.9% |
Selling, general and administrative | 71.6 | 57.1 | 49.2 | 30.0 | 25.3 |
Research and development | 4.5 | 3.9 | 3.2 | 2.3 | |
EBITA | 9.2 | 1.9 | -4.0 | -5.9 | -12.7 |
EBITA margin | 3.3% | 0.8% | -2.1% | -4.5% | -12.0% |
Amortization of intangibles | 3.1 | 3.9 | 3.4 | | 1.2 |
EBIT | 6.1 | -2.0 | -7.4 | -5.9 | -13.9 |
EBIT margin | 2.2% | -0.8% | -4.0% | -4.5% | -13.1% |
Pre-tax income | 46.1 | 34.2 | 25.0 | -4.6 | -14.5 |
Income taxes | -10.9 | -0.3 | 0.3 | 0.1 | 0.0 |
Tax rate | | | 1.2% | | 0.0% |
Net income | 13.7 | -7.1 | -14.1 | -4.7 | -14.5 |
Net margin | 4.9% | -3.0% | -7.6% | -3.6% | -13.7% |
|
Diluted EPS | $0.33 | ($0.24) | ($2.74) | ($2.23) | ($7.15) |
Shares outstanding (diluted) | 41.5 | 29.4 | 5.1 | 2.1 | 2.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|